These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
771 related articles for article (PubMed ID: 15993028)
1. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028 [TBL] [Abstract][Full Text] [Related]
2. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Lovrics PJ; Chen V; Coates G; Cornacchi SD; Goldsmith CH; Law C; Levine MN; Sanders K; Tandan VR Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737 [TBL] [Abstract][Full Text] [Related]
3. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
4. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295 [TBL] [Abstract][Full Text] [Related]
5. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958 [TBL] [Abstract][Full Text] [Related]
6. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
7. Removal of two sentinel nodes accurately stages the axilla in breast cancer. Kennedy RJ; Kollias J; Gill PG; Bochner M; Coventry BJ; Farshid G Br J Surg; 2003 Nov; 90(11):1349-53. PubMed ID: 14598413 [TBL] [Abstract][Full Text] [Related]
8. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290 [TBL] [Abstract][Full Text] [Related]
9. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
10. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968 [TBL] [Abstract][Full Text] [Related]
11. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Lee S; Kim EY; Kang SH; Kim SW; Kim SK; Kang KW; Kwon Y; Shin KH; Kang HS; Ro J; Lee ES Breast Cancer Res Treat; 2007 May; 102(3):283-8. PubMed ID: 17063280 [TBL] [Abstract][Full Text] [Related]
12. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla? Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472 [TBL] [Abstract][Full Text] [Related]
13. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226 [TBL] [Abstract][Full Text] [Related]
14. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL; Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245 [TBL] [Abstract][Full Text] [Related]
15. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. Coutant C; Rouzier R; Fondrinier E; Marchal F; Guillemin F; Seince N; Rodrigues A; Darai E; Uzan S; Barranger E Breast Cancer Res Treat; 2009 Feb; 113(3):537-43. PubMed ID: 18340527 [TBL] [Abstract][Full Text] [Related]
16. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Tan LG; Tan YY; Heng D; Chan MY Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642 [TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in patients with male breast carcinoma. Port ER; Fey JV; Cody HS; Borgen PI Cancer; 2001 Jan; 91(2):319-23. PubMed ID: 11180077 [TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Hidar S; Bibi M; Gharbi O; Tebra S; Trabelsi A; Korbi S; Bouaouina N; Ben Ahmed S; Khaïri H Int J Surg; 2009 Jun; 7(3):272-5. PubMed ID: 19410665 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of sentinel lymph node biopsy in male breast cancer. Cimmino VM; Degnim AC; Sabel MS; Diehl KM; Newman LA; Chang AE J Surg Oncol; 2004 May; 86(2):74-7. PubMed ID: 15112248 [TBL] [Abstract][Full Text] [Related]
20. Low axillary sampling in clinically node-negative operable breast cancer. Parmar V; Hawaldar R; Nadkarni MS; Badwe RA Natl Med J India; 2009; 22(5):234-6. PubMed ID: 20334043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]